{"id":837827,"date":"2025-04-16T01:03:00","date_gmt":"2025-04-16T05:03:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/"},"modified":"2025-04-16T01:03:00","modified_gmt":"2025-04-16T05:03:00","slug":"innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/","title":{"rendered":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025"},"content":{"rendered":"

<\/p>\n

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025<\/b><\/p>\n

MARSEILLE, France–(BUSINESS WIRE<\/a>)–
\nRegulatory News:\u00a0\n<\/p>\n

\nInnate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate<\/b>\u201d or the \u201cCompany<\/b>\u201d) will hold its annual general meeting of shareholders (\u201cAGM<\/b>\u201d) at 10:30 a.m. CEST on May 22, 2025 in its headquarters, 117 avenue de Luminy, 13009 Marseille.\n<\/p>\n

\nThe Notice of Meeting of this AGM was published on April 16, 2025 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM.\n<\/p>\n

\nDocuments and information relating to this meeting will be made available to shareholders in accordance with current regulations, and will also be available in the Investors section<\/a> of the Company’s website.\n<\/p>\n

****<\/b><\/p>\n

\nThe annual general meeting will also be broadcasted live and available at the following link:\n<\/p>\n

Innate Pharma 2025 annual general meeting<\/a><\/p>\n

\nA guided tour of the Company’s laboratories is organized on the same day at 9:15 a.m. CEST for shareholders. Shareholders can register for the tour at this link: company laboratories tour registration form<\/a>.\n<\/p>\n

****<\/b><\/p>\n

Precision regarding the AGM:<\/b><\/p>\n

\nOnly shareholders having registered their shares at least two business days prior to the date of the AGM, by zero hour Paris time, will be able to participate.\n<\/p>\n

\nShareholders holding \u201cau porteur<\/i>\u201d (bearer) shares will need to obtain an \u201cattestation de participation<\/i>\u201d (certificate of shareholding) from their brokers. This \u201cattestation de participation<\/i>\u201d must be attached to the voting or proxy form.\n<\/p>\n

\nWritten questions from shareholders must be received four business days prior to the AGM at the latest (by e-mail to investors@innate-pharma.fr<\/a>).\n<\/p>\n

\nShareholders can also obtain the documents and information in preparation of the AGM (as described in article R. 225-83 of the French Code de Commerce) by sending a request by e-mail to investors@innate-pharma.fr<\/a>.\n<\/p>\n

About Innate Pharma<\/b><\/p>\n

\nInnate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three therapeutic approaches: multi-specific NK Cell Engagers via its ANKET\u00ae<\/sup> (Antibody-based NK cell Engager Therapeutics) proprietary platform and Antibody Drug Conjugates (ADC) and monoclonal antibodies (mAbs).\n<\/p>\n

\nInnate\u2019s portfolio includes several ANKET\u00ae<\/sup> drug candidates to address multiple tumor types as well as IPH4502, a differentiated ADC in development in solid tumors. In addition, anti-KIR3DL2 mAb lacutamab is developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, and anti-NKG2A mAb monalizumab is developed with AstraZeneca in non-small cell lung cancer.\n<\/p>\n

\nInnate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and development for the benefit of patients.\n<\/p>\n

\nHeadquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.\n<\/p>\n

\nLearn more about Innate Pharma at www.innate-pharma.com<\/a>. Follow us on LinkedIn<\/a> and X<\/a>.\n<\/p>\n

Information about Innate Pharma shares<\/b><\/p>\n\n\n
\n

ISIN code
\n<\/b>
Ticker code
\n<\/b>
LEI<\/b><\/p>\n<\/td>\n

\n\n

\nFR0010331421\n<\/p>\n

\nEuronext: IPH Nasdaq: IPHA\n<\/p>\n

\n9695002Y8420ZB8HJE29\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

Disclaimer on forward-looking information and risk factors<\/b><\/p>\n

\nThis press release contains certain forward-looking statements, including those within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. The use of certain words, including \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccan,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cpotential,\u201d \u201cexpect\u201d \u201cshould,\u201d \u201cwill,\u201d or the negative of these and similar expressions, is intended to identify forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company\u2019s reliance on third parties to manufacture its product candidates, the Company\u2019s commercialization efforts and the Company\u2019s continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties, which could cause the Company’s actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors (\u201cFacteurs de Risque”) section of the Universal Registration Document filed with the French Financial Markets Authority (\u201cAMF\u201d), which is available on the AMF website http:\/\/www.amf-france.org<\/a> or on Innate Pharma\u2019s website, and public filings and reports filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d), including the Company\u2019s Annual Report on Form 20-F for the year ended December 31, 2023, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public by the Company. References to the Company\u2019s website and the AMF website are included for information only and the content contained therein, or that can be accessed through them, are not incorporated by reference into, and do not constitute a part of, this press release.\n<\/p>\n

\nIn light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by the Company or any other person that the Company will achieve its objectives and plans in any specified time frame or at all. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.\n<\/p>\n

\nThis press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250415963401\/en\/<\/a><\/span><\/p>\n

For additional information, please contact:
\n<\/b>
Investors
\n<\/span><\/b>
Innate Pharma
\n<\/b>
Henry Wheeler
\n
Tel.: +33 (0)4 84 90 32 88
\n
Henry.wheeler@innate-pharma.fr<\/a><\/p>\n

Media Relations
\n<\/span><\/b>
NewCap
\n<\/b>
Arthur Rouill\u00e9
\n
Tel.: +33 (0)1 44 71 00 15
\n
innate@newcap.eu<\/a><\/p>\n

KEYWORDS:<\/b> Europe United States North America France Maryland<\/p>\n

INDUSTRY KEYWORDS:<\/b> Oncology Health Research Pharmaceutical Science Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 MARSEILLE, France–(BUSINESS WIRE)– Regulatory News:\u00a0 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d) will hold its annual general meeting of shareholders (\u201cAGM\u201d) at 10:30 a.m. CEST on May 22, 2025 in its headquarters, 117 avenue de Luminy, 13009 Marseille. The Notice of Meeting of this AGM was published on April 16, 2025 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. Documents and information relating to this meeting will be made available to shareholders in accordance with current regulations, and will also be available in the Investors section … <\/p>\n

Continue reading “Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-837827","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nInnate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 MARSEILLE, France–(BUSINESS WIRE)– Regulatory News:\u00a0 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d) will hold its annual general meeting of shareholders (\u201cAGM\u201d) at 10:30 a.m. CEST on May 22, 2025 in its headquarters, 117 avenue de Luminy, 13009 Marseille. The Notice of Meeting of this AGM was published on April 16, 2025 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. Documents and information relating to this meeting will be made available to shareholders in accordance with current regulations, and will also be available in the Investors section … Continue reading "Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-16T05:03:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025\",\"datePublished\":\"2025-04-16T05:03:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/\"},\"wordCount\":995,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/\",\"name\":\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-04-16T05:03:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/","og_locale":"en_US","og_type":"article","og_title":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 - Market Newsdesk","og_description":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 MARSEILLE, France–(BUSINESS WIRE)– Regulatory News:\u00a0 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d) will hold its annual general meeting of shareholders (\u201cAGM\u201d) at 10:30 a.m. CEST on May 22, 2025 in its headquarters, 117 avenue de Luminy, 13009 Marseille. The Notice of Meeting of this AGM was published on April 16, 2025 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. Documents and information relating to this meeting will be made available to shareholders in accordance with current regulations, and will also be available in the Investors section … Continue reading \"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-16T05:03:00+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025","datePublished":"2025-04-16T05:03:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/"},"wordCount":995,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/","name":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-04-16T05:03:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415963401r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-22-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=837827"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837827\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=837827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=837827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=837827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}